Document:

Exhibit 10.2

        

      

      AMENDED AND RESTATED RESALE REGISTRATION RIGHTS AGREEMENT

       

      THIS AMENDED AND RESTATED RESALE REGISTRATION RIGHTS AGREEMENT, dated as of November 18, 2022 (this “Agreement”), has been entered into by and between VENUS CONCEPT INC., a Delaware corporation (the “Company”) and the 2022 Purchasers (as defined below).

       

      BACKGROUND

       

      Pursuant to the Stock Purchase Agreement, dated as of December 15, 2021 (the “2021 SPA”), by and between the 2021 Purchasers (as defined below) and the Company, the 2021 Purchasers purchased from the Company 9,808,418 shares of common stock of the Company (the “2021 Common Stock”) and 3,790,755 shares of nonvoting convertible preferred stock of the Company (the “2021

          Preferred Stock”), and the Company agreed to provide to the 2021 Purchasers certain resale registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder (together, the “Securities Act”), and applicable state securities laws with respect to the 2021 Covered Shares (as defined below).

       

      Pursuant to the Stock Purchase Agreement, dated as of November 18, 2022 (the “2022 SPA”), by and between the 2022 Purchasers (as defined below) and the Company, the 2022 Purchasers have agreed to purchase from the Company 1,750,000 shares of common stock of the Company (the “2022 Common Stock”) and 3,185,000 shares of voting convertible preferred stock of the Company (the “2022 Preferred Stock”), and the Company has agreed to provide to the 2022 Purchasers certain resale registration rights under the Securities Act and applicable state securities laws with respect to the 2022
        Covered Shares (as defined below).

       

      To effectuate the resale registration rights granted by the Company to the 2021 Purchasers under the 2021 SPA, the Company and the 2021 Purchasers
        entered into a Resale Registration Rights Agreement, dated December 15, 2021 (the “Prior Agreement”).  The Company and the 2022 Purchasers wish to amend and
        restate the Prior Agreement to incorporate the resale registration rights granted by the Company to the 2022 Purchasers under the 2022 SPA, on the terms and conditions set forth in this Agreement.  This Agreement has been approved and adopted in
        accordance with Section 6(d) of the Prior Agreement and shall be deemed adopted by, binding upon, and enforceable against each and every Purchaser (as defined below), regardless of whether such Purchaser has signed this Agreement.

       

      AGREEMENT

       

      In light of the above, the Prior Agreement is amended and restated as follows:

       

      
        
          
            1.           Definitions.

          

        

      

       

      As used in this Agreement, the following terms will have the respective meanings set forth in this Section 1:

       

      “2021 Common Stock” has the meaning set forth in the
        preamble.

       

      “2021 Covered Shares” means (i) any shares of 2021
        Common Stock or (ii) any shares of Common Stock issued or issuable upon conversion of the 2021 Preferred Stock.

       

      

      
        
          

      

      
      “2021 Preferred Stock” has the meaning set forth in
        the preamble.

       

      “2021 Purchasers” means the purchasers of the 2021
        Common Stock and 2021 Preferred Stock identified on the signature pages to the 2021 SPA and each successor and assignee that becomes party to the 2021 SPA.

       

      “2021 Registrable Securities” means any 2021 Covered
        Shares and any shares of capital stock issued or issuable with respect to the foregoing as a result of any stock split, reverse stock split, stock dividend, recapitalization, exchange or similar event or otherwise.

       

      “2021 SPA” has the meaning set forth in the preamble.

       

      “2022 Common Stock” has the meaning set forth in the
        preamble.

       

      “2022 Covered Shares” means (i) any shares of 2022
        Common Stock or (ii) any shares of Common Stock issued or issuable upon conversion of the 2022 Preferred Stock.

       

      “2022 Preferred Stock” has the meaning set forth in
        the preamble.

       

      “2022 Purchasers” means the purchasers of the 2022
        Common Stock and 2022 Preferred Stock identified on the signature pages to the 2022 SPA and each successor and assignee that becomes party to the 2022 SPA.

       

      “2022 Registrable Securities” means any 2022 Covered
        Shares and any shares of capital stock issued or issuable with respect to the foregoing as a result of any stock split, reverse stock split, stock dividend, recapitalization, exchange or similar event or otherwise.

       

      “2022 SPA” has the meaning set forth in the preamble.

       

      “Agreement” has the meaning set forth in the
        preamble.

       

      “Advice” has the meaning set forth in Section
        2(d)(iv).

       

      “Blue Sky” has the meaning set forth in Section 3(l).

       

      “Business Day” means (i) a day on which the Common
        Stock is traded on a Trading Market, (ii) if the Common Stock is not listed on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the National Quotation Bureau Incorporated (or any similar
        organization or agency succeeding to its functions of reporting prices) or (iii) in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, any day other than a Saturday, a Sunday or a day on which banking
        institutions in The City of New York are authorized or required by law, regulation or executive order to remain closed.

       

      “Claim” has the meaning set forth in Section 5(b).

       

      “Commission” means the Securities and Exchange
        Commission or any successor agency.

       

      “Common Stock” means the Company’s common stock, par
        value $0.0001 per share.

       

       “Company” has the meaning set forth in the preamble.

       

      
        2

        
          

      

      “Discontinuance Notice” has the meaning set forth in
        Section 3(d).

       

      “Effective Date” means, with respect to any
        Registration Statement, the date on which the Commission first declares effective such Registration Statement.

       

      “Effectiveness Deadline” means, with respect to a
        Registration Statement filed pursuant to Section 2(a), ninety (90) calendar days after the applicable Filing Deadline in the case of a filing on Form S-3 and one hundred twenty (120) calendar days after the applicable Filing Deadline in the case of
        a filing on Form S-1.

       

      “Effectiveness Period” has the meaning set forth in
        Section 2(a).

       

      “Exchange Act” means the Securities Exchange Act of
        1934, as amended, and the rules and regulations promulgated thereunder.

       

      “Filing Deadline” means, with respect to the 2021
        Registrable Securities, January 14, 2022, and with respect to the 2022 Registrable Securities, December 19, 2022.

       

      “FINRA” means the Financial Industry Regulatory
        Authority, Inc. or any successor organization performing similar functions.

       

      “Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

       

      “Indemnified Party” has the meaning set forth in
        Section 5(c).

       

      “Indemnifying Party” has the meaning set forth in
        Section 5(c).

       

      “Initial Registration Statement” has the meaning set
        forth in the definition of “Registration Statement.”

       

      “Losses” has the meaning set forth in Section 5(a).

       

      “Person” or “person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization or government or other
        agency or political subdivision thereof. Any division or series of a limited liability company, limited partnership or trust will constitute a separate “person” under this Agreement.

       

      “Plan of Distribution” has the meaning set forth in Section 2(a).

       

      “Prior Agreement” has the meaning set forth in the
        preamble.

       

      “Proceeding” means an action, claim, suit,
        investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

       

      
        3

        
          

      

      “Prospectus” means the prospectus included in a
        Registration Statement (including, without limitation, any preliminary prospectus, any free-writing prospectus and any prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration
        statement under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and
        supplements to such prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such prospectus.

       

      “Purchasers” means the 2021 Purchasers and the 2022
        Purchasers.

       

      “Registrable Securities” means the 2021 Registrable
        Securities and / or the 2022 Registrable Securities, as the context requires.  As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when (i) the Commission has declared a Registration Statement
        covering such securities effective and such securities have been disposed of pursuant to such effective Registration Statement; (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 under the
        Securities Act are met and the legend restricting further transfer has been removed from the certificate for such securities; or (iii) such securities are no longer outstanding.

       

      “Registration Default” has the meaning set forth in
        Section 2(c)(iv).

       

      “Registration Statement” means a registration
        statement filed pursuant to the terms hereof and which covers the resale of Registrable Securities by the Holders, including the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective
        amendments, all exhibits thereto and all material incorporated by reference (or deemed to be incorporated by reference) therein.  For the avoidance of doubt, “Registration

          Statement” means the initial registration statement described above in this paragraph (the “Initial Registration Statement”) and any additional registration statement or registration statements that are needed to sell additional Registrable Securities with the effect that the obligations of the Company under this
        Agreement also extend to such additional registration statement or registration statements, in all cases, as specified in this Agreement.

       

      “Rule 144” means Rule 144 promulgated by the
        Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

       

      “Rule 415” means Rule 415 promulgated by the
        Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

       

      “Rule 424” means Rule 424 promulgated by the
        Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

       

      “SEC Guidance” means (i) any publicly-available
        written or oral guidance of the SEC staff, or any comments, requirements or requests of the SEC staff whether formally or informally or publicly or privately and (ii) the Securities Act.

       

      “Securities Act” has the meaning set forth in the
        preamble.

       

      
        4

        
          

      

      “Selling Holder Questionnaire” has the meaning set
        forth in Section 2(d)(i).

       

      “Selling Securityholders” has the meaning set forth
        in Section 3(b).

       

      “Subsequent Form S-3” has the meaning set forth in
        Section 3(m).

       

      “Suspension Notice” has the meaning set forth in
        Section 2(b).

       

      “Suspension Period” has the meaning set forth in
        Section 2(b).

       

      “Trading Market” means whichever of the NYSE
        American, New York Stock Exchange, the Nasdaq Global Market, the Nasdaq Capital Market, Nasdaq Global Select Market or such other United States registered national securities exchange on which the Common Stock is listed or quoted for trading on the
        date in question.\

       

      “Underwritten Offering” shall mean a registration in
        which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

       

      
        
          
            2.           Registration.

          

        

      

       

      
        
          
            
              (a)          Mandatory Registration.

            

          

        

      

       

        

      (i)         On or prior to the applicable Filing
            Deadline, the Company will prepare and file with the Commission a Registration Statement covering the resale of the applicable Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415.  The parties
            acknowledge that a Registration Statement for the 2021 Covered Shares has already been filed and a new Registration Statement for the 2022 Covered Shares will be filed (references herein to the Registration Statement shall refer to each
            applicable Registration Statement, as applicable).  The Registration Statement will be on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration will
            be on Form S-1, and if for any reason the Company is not then eligible to register for resale the Registrable Securities on Form S-1, then  another appropriate form for such purpose) and will contain (except if otherwise required pursuant to
            written comments received from the Commission upon a review of such Registration Statement) a “Plan of Distribution” section, substantially in the form attached hereto as
            Annex A, as the same may be amended in accordance with the provisions of this Agreement.  The Company will use its reasonable best efforts to cause the Registration Statement to be declared effective under the Securities Act as soon as possible
            but, in any event, no later than the applicable Effectiveness Deadline, and will use their reasonable best efforts to keep the Registration Statement (or a Subsequent Form S-3) continuously effective under the Securities Act until such date
            when the Registrable Securities covered by the Registration Statement cease to be Registrable Securities as determined by the counsel to the Company (the “Effectiveness

              Period”).

       

      (ii)        Notwithstanding the registration
            obligations set forth in this Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single
            registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum
            number of Registrable Securities permitted to be registered by the Commission, on Form S-3 (or Form S-1, if available) or such other form available to register for resale the Registrable Securities as a secondary offering; provided, however,
            that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without
            limitation, Compliance and Disclosure Interpretation 612.09.

       

      
        5

        
          

      

      (iii)       Notwithstanding any other provision
            of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the
            Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of
            Registrable Securities to be registered on such Registration Statement will be reduced by reducing or eliminating any securities to be included other than Registrable Securities.

       

      (iv)      In the event of a cutback under this
            Section 2(a), the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder’s allotment. In the event the Company amends the Registration Statement in accordance with the
            foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form
            S-3 (or Form S-1 if available) or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement.

       

      (b)         Suspension Periods.  Notwithstanding Section 2(a), the Company may, at any time, delay the filing or delay or suspend the effectiveness of a Registration Statement or, without suspending such effectiveness, deliver a notice (a “Suspension Notice”) that instructs any selling Holders not to sell any securities included in the Registration Statement or delay the filing of any amendment or supplement
          pursuant to Section 3, if the board of directors of the Company has determined and promptly notifies the selling Holders in writing that in its reasonable good faith judgment (i) pending corporate development with respect to the Company that the
          Company believes may be material and that, in the determination of the Company, makes it materially detrimental to the Company to allow continued availability of a Registration Statement or Prospectus or (ii) such registration could reasonably be
          expected to materially interfere with any material financing, acquisition, corporate reorganization, merger, tender offer or other significant transaction involving the Company (a “Suspension Period”), by providing the selling Holders with written notice of such Suspension Period and the reasons therefor.  The Company will use its reasonable best efforts to provide such notice at least ten (10)
          Business Days prior to the commencement of such a Suspension Period; provided, however, that in any event the Company will provide such notice no later than the commencement of such Suspension Period; provided, further, that in no event will a
          Suspension Period exceed 30 days and in no event shall the total number of days subject to a Suspension Period during any consecutive 12-month period exceed 45 days. Any Suspension Period will not be deemed to end until the Holders have received
          a notice from the Company stating that such Suspension Period has ended.

       

      
        6

        
          

      

      (c)         Damages.  The
          parties hereto agree that, subject to Section 2(d), the Holders will suffer damages if the Company fails to fulfill its obligations under this Section 2 and that, in such case, it would not be feasible to ascertain the extent of such damages with
          precision.  Accordingly, if:

       

      (i)          the Company does not file a
            Registration Statement by the applicable Filing Deadline;

       

      (ii)         a Registration Statement is not
            declared effective by the Commission on or before the applicable Effectiveness Deadline;

       

      (iii)        the Company extends any Suspension
            Period beyond 45 days during any consecutive 12-month period; or

       

      (iv)       a Registration Statement is filed and
            declared effective but, during the Effectiveness Period, a Registration Statement is not effective for any reason or the Prospectus contained therein is not available for use for any reason, including by reason of its withdrawal or termination
            pursuant to Section 3(e), or, other than by reason of a Suspension Period as provided in Section 2(b), will fail to be usable for its intended purpose without such disability being cured within ten (10) Business Days by an effective
            post-effective amendment to such Registration Statement, a supplement to the Prospectus, a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures such failure or the effectiveness of a
            Subsequent Form S-3, and either (x) the Company fails for any reason to satisfy the requirements of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirement under Rule 144(c); or (y) the
            Company fails to satisfy any condition set forth in Rule 144(i)(2) as a result of which any of the Holders are unable to sell Registrable Securities without restriction under Rule 144 (including, without limitation, volume restrictions) (each
            such event referred to in foregoing clauses (i) through (iv), a “Registration Default”), then in such event as partial relief for the damages to any
            Holder by reason of any such delay in or reduction of its ability to sell the Registrable Securities and not as a penalty (which remedy will not be exclusive of any other remedies available at law or equity), the Company hereby agrees to make
            pro rata payments to each Holder, subject to Section 2(d), as liquidated damages and not as a penalty, an additional amount equal to 0.5% of the aggregate amount invested by such Holder for each 90-day period (or pro rata for any portion
            thereof) following the occurrence of any Registration Default and shall be increased by 0.5% during each subsequent 90-day period (or pro rata for any portion thereof), provided that in no event shall the additional amount per 90-day period
            exceed 2.0% and in no event shall the aggregate additional amount due pursuant to this Section 2(c)(iv) exceed 5.0% of the aggregate amount invested by such Holder.  Such payments shall constitute the Holder’s exclusive monetary remedy for such
            events, but shall not affect the right of the Holders to seek injunctive relief.  The amounts payable as liquidated damages pursuant to this paragraph shall be paid monthly within three (3) Business Days of the last day of each month following
            the commencement of the payments.  Such payments shall be made to each Holder in cash. Interest shall accrue at the rate of 1% per month on any such liquidated damages payments that shall not be paid by the due date until such amount is paid in
            full.

       

      (d)         Holders’ Agreements.  It will be a condition of each Holder’s rights under this Agreement, and each Holder agrees, as follows:

       

      
        7

        
          

      

      (i)        Cooperation & Selling Holder Questionnaire.  Such Holder will cooperate with the Company by, with reasonable promptness, supplying information and executing documents relating to such selling Holder or the
            securities of the Company owned by such selling Holder in connection with such registration which are customary for offerings of this type or is required by applicable laws or regulations, including but not limited to furnishing to the Company
            (to the extent not already furnished to the Company) a completed questionnaire in the form attached to this Agreement as Annex B (a “Selling Holder
              Questionnaire”).  The Company will not be required to include the Registrable Securities of a Holder in a Registration Statement and will not be required to pay any damages under Section 2(c) to any Holder who fails to furnish to the
            Company a fully completed Selling Holder Questionnaire at least five (5) Business Days prior to the applicable Filing Deadline.

       

      (ii)       Undertakings.  Such selling Holder will enter into any undertakings and take such other action relating to the conduct of the proposed offering which the Company may reasonably request as being necessary to insure
            compliance with federal and state securities laws and the rules or other requirements of FINRA.

       

      (iii)        Shelf Sales.  In connection with and as a condition to the Company’s obligations with respect to any shelf Registration Statement, each Holder covenants and agrees that it will not offer or sell any such Registrable
            Securities under the Registration Statement until the Registration Statement has been declared effective by the Commission and such Holder has provided a written notice to the Company of such proposed sale.  The Company and the Holders
            acknowledge and agree that in no way shall this clause limit Holder’s ability to sell securities without using the Registration Statement.

       

      (iv)       Discontinuance of Sales.  Each Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a Suspension Notice or a Discontinuance Notice from the Company, such Holder will forthwith
            discontinue any offers and sales of such Registrable Securities under the Registration Statement until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised in writing
            (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or
            supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement.  The Company and the Holders acknowledge and agree that in no way shall this clause limit Holder’s ability to
            sell securities without using the Registration Statement.

       

      
        8

        
          

      

      (e)        Piggyback Registrations.  Without limiting any obligation of the Company, if the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities
          Act of any of its equity or equity-linked securities (other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity or equity-linked securities to be issued solely in connection
          with any acquisition of any entity or business (or a business combination subject to Rule 145 under the Securities Act) or equity or equity-linked securities issuable in connection with the Company’s stock option or other employee benefit plans),
          or a dividend reinvestment or similar plan or rights offering, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen (15) calendar days after the date of the delivery of such notice, any such
          Holder shall so request in writing, the Company shall include in such registration statement or offering statement all or any part of such Registrable Securities that such Holder requests to be registered (a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing underwriter or
          underwriters of a proposed Underwritten Offering in connection with such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant to this Section 2(e)
          to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such registration and to permit the sale or other disposition of such Registrable Securities in accordance with the
          intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this Section 2(e) shall enter
          into an underwriting agreement in customary form with the underwriter(s) selected for such Underwritten Offering by the Company.  The Company may postpone or withdraw the filing or the effectiveness of a Piggyback Registration at any time in its
          sole discretion. The Company shall not grant piggyback registration rights to any holders of its Common Stock or securities that are convertible into its Common Stock that are senior to the rights of the Holders set forth in this Section 2(e).

       

      3.          Registration Procedures.  In
          connection with the Company’s obligations to effect a registration pursuant to Section 2(a), the Company and, as applicable, the Holders, will do the following:

       

      (a)          FINRA Cooperation.  The
          Company and the Holders will cooperate and assist in any filings required to be made with FINRA.

       

      (b)        Right to Review Prior Drafts. 

          Not less than ten (10) Business Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement thereto, the Company will furnish to each Holder copies of the “Selling Securityholders” and “Plan of Distribution” sections of such documents (together with
          drafts of the Registration Statement or any related Prospectus or any amendment or supplement thereto) in the form in which the Company proposes to file them, which sections and documents will be subject to the review of each such Holder.  Each
          Holder will provide comments, if any, within five (5) Business Days after the date such materials are provided.  The Company will not file a Registration Statement, any Prospectus or any amendments or supplements thereto in which the “Selling Securityholders” or the “Plan of Distribution” sections
          thereof differ in any material respect from the disclosure received from a Holder in its Selling Holder Questionnaire (as amended or supplemented) or otherwise differ in any material respect from the drafts previously received by such Holder.

       

      (c)        Right to Copies.  The
          Company will furnish to each Holder and the managing underwriters, if any, without charge, (i) at least one (1) conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such Holder
          (excluding those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission, except if such documents are available on EDGAR; and (ii) as many copies of each Prospectus or Prospectuses
          (including each form of prospectus) and each amendment or supplement thereto as such Holder may reasonably request.  The Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders
          or managing underwriters, as applicable, in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto.

       

      
        9

        
          

      

      (d)        Notices.  The Company will
          notify each Holder covered by the Registration Statement as promptly as reasonably practicable: (A) when the Prospectus or any prospectus supplement or post-effective amendment has been filed, and with respect to the Registration Statement or any
          post-effective amendment, when the same has become effective; (B) of any request by the Commission for any amendments or supplements to the Registration Statement or the Prospectus or for additional information; (C) of the issuance by the
          Commission of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (D) if, at any time prior to the closing contemplated by the 2021 SPA or 2022 SPA, as applicable, it
          becomes aware that the representations and warranties of the Company contained in such agreement cease to be true and correct; (E) of the receipt by the Company of any notification with respect to the suspension of the qualification of the
          Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (F) of the happening of any event which it believes may make any statement made in the Registration Statement, the Prospectus
          or any document incorporated therein by reference untrue, or of any material misstatement or omission, and which requires the making of any changes in the Registration Statement, the Prospectus or any document incorporated therein by reference in
          order to make the statements therein not misleading; (G) upon the occurrence of a Suspension Period (items (C) through and including (G) being a “Discontinuance
            Notice”); and (H) upon the conclusion of a Suspension Period.

       

      (e)         Withdrawal of Suspension Orders. The Company will use its reasonable best efforts to respond as promptly as reasonably possible to any comments received from the Commission with respect to any Registration Statement or any amendment thereto and to obtain the withdrawal
          of any order suspending the effectiveness of the Registration Statement or the suspension of the qualification of the Registrable Securities for sale in any jurisdiction, or to prevent any such suspension.

       

      (f)          Supplements & Amendments.  Subject to Sections 2(a), if required by applicable federal securities laws, based on the advice of the Company’s counsel, the Company will prepare a supplement or post-effective amendment to a Registration Statement, the related
          Prospectus or any document incorporated therein by reference or file any other required document or, if necessary, renew or refile a Registration Statement prior to its expiration, so that, as thereafter delivered to the purchasers of the
          Registrable Securities, (A) the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading; (B) such Registration Statement remains continuously
          effective as to the applicable Registrable Securities for its applicable Effectiveness Period; (C) the related Prospectus may be supplemented by any required prospectus supplement, and as so supplemented may be filed pursuant to Rule 424 and (D)
          the Prospectus will be supplemented, if necessary, to update the disclosure of the number of shares that each Holder intends to sell, reflecting prior resales in accordance with guidance of the staff of the Commission (as such guidance may be
          substituted for, amended or supplemented by the staff of the Commission after the date of this Agreement).  Furthermore, subject to a Holder’s compliance with its obligations under Section 2(d)(i), the Company will take such actions as are
          required to name such Holder as a selling Holder in a Registration Statement or any supplement thereto and to include (to the extent not theretofore included) in such Registration Statement the Registrable Securities identified in such Holder’s
          Selling Holder Questionnaire.

       

      
        10

        
          

      

      (g)         Listing.  The Company will
          use its commercially reasonable efforts to cause all 2021 Covered Shares and 2022 Covered Shares that constitute Registrable Securities covered by the Registration Statement to be listed on each securities exchange on which identical securities
          issued by the Company are then listed if requested by the Holder thereof and, if not so listed, to be approved for listing on the national securities exchange on which the Common Stock is then listed.

       

      (h)       Transfer Agent & Registrar.  The Company will provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement from and after a date not later than the Effective Date of such Registration
          Statement.

       

      (i)          Certificates.  The Company
          will cooperate with the Holders to facilitate the timely preparation and delivery of any certificates representing Registrable Securities to be delivered to a transferee pursuant to any Registration Statement, which certificates will be free of
          all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably request.

       

      (j)        CUSIPs.  The Company, if
          necessary, will use its best efforts to provide a CUSIP number for the Registrable Securities, not later than the Effective Date of the Registration Statement.

       

      (k)        Legal Counsel.  Holders will
          have the right to select one legal counsel, at the Company’s reasonable expense pursuant to Section 4, to review any Registration Statement or Prospectus prepared pursuant to Section 2 or this Section 3, which will be such counsel as designated
          by the Holders of a majority of the Registrable Securities then outstanding.  The Company will reasonably cooperate with such legal counsel’s reasonable requests in performing their obligations under this Agreement.

       

      (l)          Blue Sky.  If at any time
          the Registrable Securities are not “Covered Securities within the meaning of Rule 146 of the Securities Act, the Company will, prior to any public offering of Registrable Securities, use its reasonable best efforts to register or qualify or
          cooperate with the selling Holders , in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities or blue sky laws (“Blue Sky”) of all jurisdictions within the United States that the selling Holders request in writing be covered, to keep each such registration or
          qualification (or exemption therefrom) effective during the applicable Effectiveness Period and to do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by
          any Registration Statement; provided, that the Company will not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to become subject to any material tax in any such jurisdiction where it is
          not then so subject.

       

      
        11

        
          

      

      (m)        Subsequent Form S-3.  If, at
          the time of filing of a Registration Statement, the Company is not eligible to use Form S-3 for transactions involving secondary offerings and the Company is not otherwise eligible to incorporate by reference prospectively into such Registration
          Statement, then at such time as the Company becomes eligible to register transactions involving secondary offerings on Form S-3, the Company may, in its sole discretion, file in accordance with the procedures outlined in this Section 3, including
          but not limited to all required notices to the Holders, an additional Registration Statement on Form S-3 to cover resales pursuant to Rule 415 of the Registrable Securities (a “Subsequent Form S-3”), and, when such Subsequent Form S-3 has been filed with the Commission, the Company may, concurrently with its filing of a request for acceleration of effectiveness of such Subsequent Form S-3,
          withdraw or terminate the original Registration Statement; provided, however, that nothing in this Section 3(m) will be interpreted to limit the Company’s obligations pursuant to Section 2(a).

       

      4.           Registration Expenses.

       

      All fees and expenses incident to the performance of or compliance with this Agreement by the Company will be borne by the Company whether or not
        any Registrable Securities are sold pursuant to a Registration Statement including, without limitation: (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any
        Trading Market on which the Common Stock is then listed for trading, (B) related to compliance with applicable state securities or Blue Sky laws and (C) incurred in connection with the preparation or submission of any filing with FINRA); (ii)
        printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing Prospectuses); (iii) messenger, telephone and delivery expenses; (iv) fees and disbursements of counsel for the Company
        and counsel pursuant to Section 3(k); (v) Securities Act liability insurance, if the Company so desires such insurance; (vi) fees and expenses of all other persons retained by the Company in connection with the consummation of the transactions
        contemplated by this Agreement and (vii) all of the Company’s own internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its
        officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder;
        provided, however, that each selling Holder will pay (i) all underwriting discounts, commissions, fees and expenses and all transfer taxes with respect to the Registrable Securities sold by such selling Holder; (ii) any fees and expenses of legal
        counsel other than the counsel selected pursuant to Section 3(k) and (iii) all other expenses incurred by such selling Holder and incidental to the sale and delivery of the shares to be sold by such Holder.

       

      
        12

        
          

      

      5.           Indemnification.

       

      (a)          Indemnification by the Company.  The Company will, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, partners, members and shareholders of each Holder and each person who controls any
          Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the directors and officers of any such controlling persons, to the fullest extent permitted by applicable law, from and against any and all
          losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or based upon, in the case of the Registration Statement or in any amendments thereto, any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged
          omission to state therein a material fact required to be stated therein to make the statements not misleading, or in the case of any Prospectus or form of prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus,
          any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the
          circumstances under which they were made, not misleading, except to the extent, but only to the extent, that such untrue statements or omissions (1) are made in reliance upon and in conformity with written information furnished to the Company by
          or on behalf of any Holder expressly for use in a Registration Statement, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in
          writing by such Holder for use in the Registration Statement, such Prospectus or such form of Prospectus (it being understood and agreed that the only such information furnished to the Company by or on behalf of any Holder consists of the
          information described in Annex A hereto, as may be amended in accordance with the provisions of this Agreement, for this purpose) or (2) resulted from the use by any Holder of an outdated or defective Prospectus after the Company has notified
          such Holder in writing that such Prospectus is outdated or defective and prior to the receipt by such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the
          amended or supplemented Prospectus the misstatement or omission giving rise to such Loss would have been corrected.

       

      (b)        Indemnification by Holders.  Each Holder will, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, partners, members and shareholders and each person who controls the Company (within the meaning of Section
          15 of the Securities Act or Section 20 of the Exchange Act) and the directors and officers of such controlling person, in each case to the fullest extent permitted by applicable law from and against all Losses, as incurred, arising solely out of
          or based upon, in the case of the Registration Statement or in any amendments thereto, any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be
          stated therein to make the statements not misleading, or in the case of any Prospectus or form of prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus, any untrue or alleged untrue statement of a material fact
          contained therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading to the
          extent, but only to the extent, that such untrue statements or omissions (1) are made in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Holder expressly for use in a Registration Statement
          or Prospectus, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder for use in the Registration Statement
          or Prospectus (it being understood and agreed that the only such information furnished to the Company by or on behalf of any Holder consists of the information described in Annex A hereto, as may be amended in accordance with the provisions of
          this Agreement, for this purpose) or (2) resulted from the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by
          such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission giving rise to such Loss would have
          been corrected; provided, however, that the obligation to indemnify will be several and not joint and in no event will the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by any
          such selling Holder upon the sale of the Registrable Securities under the Registration Statement giving rise to such indemnification obligation.

       

      
        13

        
          

      

      (c)         Conduct of Indemnification Proceedings.  In order for a Person (the “Indemnified Party”) to be entitled to any indemnification provided for under this Agreement in
          respect of, arising out of or involving a claim or demand made by any Person against the Indemnified Party (a “Claim”), such Indemnified Party must notify
          the indemnifying party (“Indemnifying Party”) in writing, and in reasonable detail, of the Claim as promptly as reasonably possible after receipt by such
          Indemnified Party of notice of the Claim; provided, however, that failure to give such notification on a timely basis shall not affect the indemnification provided hereunder except to the extent the Indemnifying Party shall have been actually
          materially prejudiced as a result of such failure.  Thereafter, the Indemnified Party shall deliver to the Indemnifying Party, promptly after the Indemnified Party’s receipt thereof, copies of all notices and documents (including court filings
          and related papers) received by the Indemnified Party relating to the Claim.

       

      If a Claim is made against an Indemnified Party, the Indemnifying Party shall be entitled to participate in the defense thereof and, if it so
        chooses and acknowledges its obligation in writing to indemnify the Indemnified Party therefor, to assume at its cost the defense thereof with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party and to
        settle such suit, action, claim or proceeding in its discretion with an unconditional full release of the Indemnified Party and no admission of fault, liability, culpability or a failure to act by or on behalf of the Indemnified Party. 
        Notwithstanding any acknowledgment made pursuant to the immediately preceding sentence, the Indemnifying Party shall continue to be entitled to assert any limitation to the amount of Losses for which the Indemnifying Party is responsible pursuant
        to its indemnification obligations.  Should the Indemnifying Party so elect to assume the defense of a Claim, the Indemnifying Party shall not be liable to the Indemnified Party for legal expenses subsequently incurred by the Indemnified Party in
        connection with the defense thereof unless (i) the Indemnifying Party has materially failed to defend, contest or otherwise protest in a timely manner against Claims or (ii) such Indemnified Party reasonably objects to such assumption on the
        grounds that there are defenses available to it which are different from or in addition to the defenses available to such Indemnifying Party and, as a result, a conflict of interest exists.  Subject to the limitations in the preceding sentence, if
        the Indemnifying Party assumes such defense, the Indemnified Party shall have the right to participate in the defense thereof and to employ counsel, at its own expense, separate from the counsel employed by the Indemnifying Party, it being
        understood, however, that the Indemnifying Party shall control such defense.  The Indemnifying Party shall be liable for the fees and expenses of counsel employed by the Indemnified Party for any period during which the Indemnifying Party has not
        assumed the defense thereof.  If the Indemnifying Party chooses to defend any Claim, all the parties hereto shall cooperate in the defense or prosecution of such Claim.  Such cooperation shall include the retention and (upon the Indemnifying
        Party’s request) the provision to the Indemnifying Party of records and information which are reasonably relevant to such Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any
        material provided hereunder.  Whether or not the Indemnifying Party shall have assumed the defense of a Claim, the Indemnified Party shall not admit any liability with respect to, or settle, compromise or discharge, such Claim without the
        Indemnifying Party’s prior written consent (which consent shall not be unreasonably withheld).

       

      
        14

        
          

      

      The obligations of the Company and the Holders under this Section 5 shall survive completion of any offering of Registrable Securities pursuant to a
        Registration Statement and the termination of this Agreement.  The Indemnifying Party’s liability to any such Indemnified Party hereunder shall not be extinguished solely because any other Indemnified Party is not entitled to indemnity hereunder.

       

      (d)        Contribution.  If
          a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, will contribute to the amount
          paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that
          resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party will be determined by reference to, among other things, whether any action in question, including
          any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’
          relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission.  The amount paid or payable by a party as a result of any Losses will be deemed to include, subject to the limitations set
          forth in Section 5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification
          provided for in Section 5(a) or 5(b) was available to such party in accordance with its terms.  The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5 were determined by pro rata allocation or
          by any other method of allocation that does not take into account the equitable considerations referred to in this Section 5.  Notwithstanding the provisions of this Section 5, no Holder will be required to contribute, in the aggregate, any
          amount in excess of the amount by which the proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by
          reason of such untrue or alleged untrue statement or omission or alleged omission.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who
          was not guilty of such fraudulent misrepresentation.

       

      (e)        Other.  The
          indemnity and contribution agreements contained in this Section 5 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

       

      6.           Miscellaneous.

       

      (a)        Notices.  All
          notices or other communications hereunder will be in writing and will be given by (i) personal delivery, (ii) courier or other delivery service which obtains a receipt evidencing delivery, (iii) registered or certified mail (postage prepaid and
          return receipt requested) or (iv) facsimile or similar electronic device, to such address as may be designated from time to time by the relevant party, and which will initially be:

       

        

      
        15

        
          

      

      (i)          in the case of the Company:

       

      Venus Concept Inc.

      235 Yorkland Blvd., Suite 900

      Toronto, Ontario, Canada

      M2J 4Y8

      Attn: General Counsel and Corporate Secretary

      Email: mmandarello@venusconcept.com

       

      With a copy to:

       

      Dorsey & Whitney LLP

      TD Canada Trust Tower

      Brookfield Place 161 Bay Street, Suite 4310

      Toronto, ON M5J 2S1

      Attn:  Richard Raymer

      Email:  raymer.richard@dorsey.com

       

      (ii)         in the case of each Purchaser, to
            the address described in Section 5.4 of the Purchase Agreement.

       

      Notices to Holders shall be provided to the address specified on such Holder’s Selling Holder Questionnaire.  All notices and other communications
        will be deemed to have been given (i) if delivered by the United States mail, three (3) Business Days after mailing (five (5) Business Days if delivered to an address outside of the United States), (ii) if delivered by a courier or other delivery
        service, one (1) Business Day after dispatch (two (2) Business Days if delivered to an address outside of the United States) and (iii) if personally delivered or sent by facsimile or similar electronic device, upon receipt by the recipient or its
        agent or employee (which, in the case of a notice sent by facsimile or similar electronic device, will be the time and date indicated on the transmission confirmation receipt).  No objection may be made by a party to the manner of delivery of any
        notice actually received in writing by an authorized agent of such party.

       

      (b)         Governing Law; Jurisdiction; Jury Trial; Etc..  This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York.  Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
          sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to
          assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
          proceeding is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it
          under this Agreement and agrees that such service will constitute good and sufficient service of process and notice thereof.  Nothing contained herein will be deemed to limit in any way any right to serve process in any manner permitted by law. 
          Each party hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication of any dispute hereunder or in connection with or arising out of this Agreement or any transaction contemplated hereby.

       

      
        16

        
          

      

      (c)          Remedies.  In
          the event of a breach by the Company of its obligations under this Agreement, each Holder, in addition to being entitled to exercise all rights granted by law,  including recovery of damages, will be entitled to specific performance of its rights
          under this Agreement.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of any of the provisions of this Agreement and hereby waives the defense in any action for
          specific performance that a remedy at law would be adequate.

       

      (d)        Entire Agreement; Amendment and Restatement.  This Agreement and any documents referred to herein or executed contemporaneously herewith constitute the parties’ entire agreement with respect to the subject matter hereof and supersede all agreements,
          representations, warranties, statements, promises and understandings, whether oral or written, with respect to the subject matter hereof.  Without limiting the generality of the foregoing, the Prior Agreement is hereby amended in its entirety and
          restated as set forth herein, and all provisions of, rights granted and covenants made in the Prior Agreement are hereby superseded in their entirety.  This Agreement has been approved and adopted in accordance with Section 6(d) of the Prior
          Agreement and shall be deemed adopted by, binding upon, and enforceable against each and every Purchaser, regardless of whether such Purchaser has signed this Agreement.

       

      (e)        Amendments.  This
          Agreement may be amended, altered or modified only by a writing signed by the Company and the Holders of a majority of the Registrable Securities then outstanding.

       

      (f)          Additional Documents.  Each party hereto agrees to execute any and all further documents and writings and to perform such other actions which may be or become necessary or expedient to effectuate and carry out this Agreement.

       

      (g)         Third-Party Beneficiaries.  None of the provisions of this Agreement will be for the benefit of, or enforceable by, any third-party beneficiary, except with respect to the Holders.

       

      (h)       Successors and Assigns.  Except as provided herein to the contrary, this Agreement will be binding upon and inure to the benefit of the parties, their respective successors and permitted assigns.

       

      (i)          Waivers Strictly Construed.  With regard to any power, remedy or right provided herein or otherwise available to any party hereunder (a) no waiver or extension of time will be effective unless expressly contained in a writing signed by the waiving
          party and (b) no alteration, modification or impairment will be implied by reason of any previous waiver, extension of time, delay or omission in exercise, or other indulgence.

       

      (j)          Severability. 
          The validity, legality or enforceability of the remainder of this Agreement will not be affected even if one or more of the provisions of this Agreement will be held to be invalid, illegal or unenforceable in any respect.

       

      (k)        Attorneys’ Fees. 
          Should any litigation be commenced (including any proceedings in a bankruptcy court) between the parties hereto or their representatives concerning any provision of this Agreement or the rights and duties of any person or entity hereunder, the
          party or parties prevailing in such proceeding will be entitled, in addition to such other relief as may be granted, to the attorneys’ fees and court costs incurred by reason of such litigation.

       

      
        17

        
          

      

      (l)         Headings.  The
          Section headings in this Agreement are inserted only as a matter of convenience, and in no way define, limit, extend or interpret the scope of this Agreement or of any particular Section.

       

      (m)        Counterparts. 
          This Agreement may be executed simultaneously in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

        

      

      [Remainder of Page Intentionally Left Blank, Signature Pages to Follow]

       

      

      
        18

        
          

      

      IN WITNESS WHEREOF, the parties have executed
          this Amended and Restated Resale Registration Rights Agreement as of the date first written above.

       

      	 	
              VENUS CONCEPT INC.

            
	 	 
	 	
              By:

                

            	/s/ Rajiv De Silva	 

      	 	
              Name: 

              

            	Rajiv De Silva
	 	
              Title:

              

            	CEO

      
         

        

        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

         

        

      

      
        
          

      

      IN WITNESS WHEREOF, the parties have executed
          this Amended and Restated Resale Registration Rights Agreement as of the date first written above.

       

      	 	
              2022 PURCHASERS:

            	 
	 	 	 
	 	
              MARLIN FUND, LIMITED PARTNERSHIP

            	 
	 	 	 
	 	
              By:

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	Michael W. Masters
	 	
              Title: 

              

            	Managing Member of the General Partner

       

      

      	 	
              MARLIN FUND II, LIMITED PARTNERSHIP

            	 
	 	 	 
	 	
              By:

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	Michael W. Masters
	 	
              Title:

              

            	Managing Member of the General Partner

      

      

      	 	
              MARLIN FUND III, LIMITED PARTNERSHIP

            
	 	 
	 	
              By: 

              

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	Michael W. Masters
	 	
              Title: 

              

            	Managing Member of the General Partner

       

      

      	 	
              MARLIN MASTER FUND OFFSHORE II, LP

            
	 	 
	 	
              By:

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	 Michael W. Masters
	 	
              Title:

              

            	 Managing Member of the General Partner

      

      

      
        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

      

      

      

      
        
          

      

      	 	
              MSS VC SPV LP

            	 
	 	 	 
	 	
              By: MSS VC SPV GP, LLC, its general partner

            	 
	 	 	 
	 	
              By: Masters Special Situations, LLC, its managing  member

            	 
	 	 	 
	 	
              By:

              

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	Michael W. Masters
	 	
              Title: 

              

            	Managing Member

       

      

      	 	
              MASTERS SPECIAL SITUATIONS, LLC

            	 
	 	 	 	 
	 	
              By:

              

            	/s/ Michael W. Masters	 

      	 	
              Name:

              

            	Michael W. Masters
	 	
              Title:

              

            	Managing Member

      
         

        

        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

         

        

      

      
        
          

      

      	 	
              EW HEALTHCARE PARTNERS, L.P.

            	 
	 	 	 
	 	
              By:

            	/s/ Scott Barry	 

      	 	
              Name:

              

            	Scott Barry
	 	
              Title:

              

            	Its Authorized Signatory

       

      

      	 	
              EW HEALTHCARE PARTNERS-A, L.P.

            	 
	 	 	 
	 	
              By: 

              

            	/s/ Scott Barry	 

      	 	
              Name:

              

            	Scott Barry
	 	
              Title:

              

            	Its Authorized Signatory

      
         

        

        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

         

        

      

      
        
          

      

      	 	
              HEALTHQUEST PARTNERS II, L.P.

            	 
	 	 	 
	 	By: Health Quest Venture Management II, L.L.C, its general partner

            
	 	 	 
	 	
              By: 

              

            	/s/ Garheng Kong	 

      	 	
              Name:

              

            	Garheng Kong
	 	
              Title:

              

            	Managing Partner

       

      

      
        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

      

       

      

      
        
          

      

      	 	
              RAJIV DE SILVA

            	 
	 	 	 
	 	
              Signed:

              

            	
              /s/ Rajiv De Silva

            	 

      
         

        

        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

         

        

      

      
        
          

      

      	 	
              HEMANTH VARGHESE

            	 
	 	 	 
	 	
              Signed:

              

            	
              /s/ Hemanth Varghese

            	 

      
         

        

        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

         

        

      

      
        
          

      

      	 	
              S. TYLER HOLLMIG, M.D.

            	 
	 	 	 
	 	
              Signed:

              

            	
              /s/ S. Tyler Hollmig, M.D.

            	 

       

      
        [Signature Page to Amended and Restated Resale Registration Rights Agreement]

      

       

      

      
        
          

      

      
      PLAN OF DISTRIBUTION

       

      We are registering the Securities covered by this prospectus on behalf of the Selling Securityholders.  All costs, expenses and fees connected with
        the registration of these Securities will be borne by us.  Any brokerage commissions and similar expenses connected with selling the Securities will be borne by the Selling Securityholders.  The Selling Securityholders may offer and sell the
        Securities covered by this prospectus from time to time in one or more transactions. The term “Selling Securityholders” includes pledgees, donees,
        transferees and other successors-in-interest who may acquire Securities through a pledge, gift, partnership distribution or other non-sale related transfer from the Selling Securityholders.  The Selling Securityholders will act independently of the
        Company in making decisions with respect to the timing, manner and size of each sale.  These transactions include:

       

      
        
          
            
              
                	 	
                        •

                      	
                        in “at the market offerings” within the meaning of Rule 415(a)(4) under the Securities Act, to or through a market maker or into an existing trading market, on an
                          exchange or otherwise;

                      

              

            

             

            

          

        

      

      
        	 	
                •

              	
                directly to a limited number of purchasers or to a single purchaser;

              

         

        

      

      
        	 	
                •

              	
                through agents;

              

         

        

      

      
        	 	
                •

              	
                by delayed delivery contracts or by remarketing firms;

              

         

        

      

      
        	 	
                •

              	
                ordinary brokerage transactions and transactions in which the broker solicits purchasers;

              

         

        

      

      
        	 	
                •

              	
                purchases by a broker-dealer as principal and resale by the broker-dealer for its own account pursuant to this prospectus;

              

         

        

      

      
        	 	
                •

              	
                exchange or over-the-counter distributions in accordance with the rules of the exchange or other market;

              

         

        

      

      
        	 	
                •

              	
                block trades in which the broker-dealer attempts to sell the Securities as agent but may position and resell a portion of the block as principal to facilitate the
                  transaction, or in crosses, in which the same broker acts as agent on both sides of the trade;

              

         

        

      

      
        	 	
                •

              	
                transactions in options, swaps or other derivatives that may or may not be listed on an exchange;

              

         

        

      

      
        	 	
                •

              	
                through distributions by a Selling Securityholder or its successors in interest to its members, general or limited partners or shareholders (or their respective members,
                  general or limited partners or shareholders);

              

         

        

      

      
        	 	
                •

              	
                a combination of any such method of sale; or

              

         

        

      

      
        	 	
                •

              	
                any other method permitted pursuant to applicable law.

              

      

       

      
        1

        
          

      

      In connection with distributions of the Securities or otherwise, the Selling Securityholders may:

       

      
        
          
            	 	
                    •

                  	
                    sell the Securities:

                  

             

            

          

        

      

      
        
          
            
              
                
                  
                    	 	
                            •

                          	
                            in negotiated transactions;

                          

                     

                    

                  

                

              

            

          

        

      

      
        	 	
                •

              	
                in one or more transactions at a fixed price or prices, which may be changed from time to time;

              

         

        

      

      
        	 	
                •

              	
                at market prices prevailing at the times of sale;

              

         

        

      

      
        	 	
                •

              	
                at prices related to such prevailing market prices; or

              

         

        

      

      
        	 	
                •

              	
                at negotiated prices;

              

         

        

      

      
        	 	
                •

              	
                sell the Securities:

              

         

        

      

      
        	 	
                •

              	
                on a national securities exchange;

              

         

        

      

      
        
          
            	 	
                    •

                  	
                    in the over-the-counter market; or

                  

             

            

          

        

      

      
        	 	
                •

              	
                in transactions otherwise than on an exchange or in the over-the-counter market, or in combination;

              

         

        

      

      
        	 	
                •

              	
                enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to them of Securities covered by this prospectus, which
                  they may in turn resell; and

              

         

        

      

      
        	 	
                •

              	
                pledge Securities to broker-dealers or other financial institutions, which, upon a default, they may in turn resell.

              

      

       

      

      The Selling Securityholders may also resell all or a portion of the Securities in open market transactions in reliance upon Rule 144 under the
        Securities Act of 1933, as amended, or the Securities Act, as permitted by that rule, Section 4(a)(1) under the Securities Act, if available, or any other exemption from the registration requirements that become available, rather than under this
        prospectus.

       

      If underwriters are used in the sale of any Securities, such Securities will be acquired by the underwriters for their own account and may be resold
        from time to time in one or more transactions described above.  Securities may be either offered to the public through underwriting syndicates represented by managing underwriters or directly by underwriters.  We may use underwriters with whom we
        have a material relationship.  As applicable, we will describe in each accompanying prospectus supplement the name of the underwriter(s) and the nature of any such relationship(s).

       

      Securities may be sold directly or through agents designated from time to time.  We will name any agent involved in the offering and sale of such
        shares and we will describe any commissions paid to the agent in the prospectus supplement.  Unless the prospectus supplement states otherwise, the agent will act on a best-efforts basis for the period of its appointment.

       

      
        2

        
          

      

      Agents may be entitled to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or to
        contribution with respect to payments made by the agents, under agreements between us and the agents.

       

      Agents may receive compensation in the form of discounts, concessions or commissions from us or our purchasers, as their agents in connection with
        the sale of securities.  These agents may be considered to be underwriters under the Securities Act.  As a result, discounts, commissions or profits on resale received by the agents may be treated as underwriting discounts and commissions.  Each
        accompanying prospectus supplement will identify any such agent and describe any compensation received by them from us.

       

      In connection with sales of Securities, the Selling Securityholders may enter into hedging transactions with broker-dealers or other financial
        institutions, which may in turn engage in short sales of Securities in the course of hedging in positions they assume.  The Selling Securityholders may also sell Securities short and the Selling Securityholders may deliver Securities covered by
        this prospectus to close out short positions and to return borrowed Securities in connection with such short sales.  The Selling Securityholders may also loan or pledge Securities to broker-dealers that in turn may sell such Securities, to the
        extent permitted by applicable law.  The Selling Securityholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to
        such broker-dealer or other financial institution of Securities offered by this prospectus, which Securities such broker-dealer or other financial institution may resell pursuant to this prospectus  (as supplemented or amended to reflect such
        transaction).

       

      The Selling Securityholders may, from time to time, pledge or grant a security interest in some or all of the Securities owned by them and, if they
        default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Securities from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable
        provision of the Securities Act, amending, if necessary, the list of Selling Securityholders to include the pledgee, transferee or other successors in interest as Selling Securityholders under this prospectus.  The Selling Securityholders may also
        may transfer and donate Securities in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.

       

      A Selling Securityholder that is an entity may elect to make an in-kind distribution of Securities to its members, general or limited partners or
        shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that such members, general or limited partners or shareholders are not affiliates of ours, such members, partners or
        shareholders would thereby receive freely tradable Securities pursuant to the distribution through a registration statement. Additionally, to the extent that entities, members, partners or shareholders are affiliates of ours received shares in any
        such distribution, such affiliates will also be Selling Securityholders and will be entitled to sell Securities pursuant to this prospectus.

       

      
        3

        
          

      

      Agents who may become involved in the sale of Securities may engage in transactions with, and perform other services for, us in the ordinary course
        of their business for which they receive compensation.

       

      In effecting sales, the Selling Securityholders may engage broker-dealers or agents, who may in turn arrange for other broker-dealers to
        participate.  Broker-dealers or agents may receive commissions, discounts or concessions from the Selling Securityholders and/or from the purchasers of Securities for whom the broker-dealers may act as agents or to whom they sell as principal, or
        both.  The compensation to a particular broker-dealer may be in excess of customary commissions.  To our knowledge, there is currently no plan, arrangement or understanding between any Selling Securityholders and any broker-dealer or agent
        regarding the sale of any Securities by the Selling Securityholders.

       

      The Selling Securityholders, any broker-dealers or agents and any participating broker-dealers that act in connection with the sale of the
        Securities covered by this prospectus may be “underwriters” under the Securities Act with respect to those Securities and will be subject to the prospectus delivery requirements of that Act.  Any profit that the Selling Securityholders realize, and
        any compensation that any broker-dealer or agent may receive in connection with any sale, including any profit realized on resale of Securities acquired as principal, may constitute underwriting discounts and commissions.  If the Selling
        Securityholders are deemed to be underwriters, the Selling Securityholders may be subject to certain liabilities under statutes including, but not limited to, Section 11, 12 and 17 of the Securities Act and Section 10(b) and Rule 10b-5 under the
        Exchange Act.

       

      The securities laws of some states may require the Selling Securityholders to sell the Securities in those states only through registered or
        licensed brokers or dealers.  These laws may also require that we register or qualify the Securities for sale in those states unless an exemption from registration and qualification is available and the Selling Securityholders and we comply with
        that exemption.  In addition, the anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934 may apply to sales of Securities in the market and to the activities of the Selling Securityholders and their affiliates. 
        Regulation M may restrict the ability of any person engaged in the distribution of the Securities to engage in market-making activities with respect to the Securities.  All of the foregoing may affect the marketability of the Securities and the
        ability of any person to engage in market-making activities with respect to the Securities.

       

      If any Selling Securityholder notifies us that he has entered into any material arrangement with a broker-dealer for the sale of Securities through
        a block trade, special offering, exchange distribution, over‐the-counter distribution or secondary distribution, or a purchase by a broker or dealer, we will file any necessary supplement to this prospectus to disclose:

       

      
        
          
            	 	
                    •

                  	
                    the number of Securities involved in the arrangement;

                  

             

            

          

        

      

      
        	 	
                •

              	
                the terms of the arrangement, including the names of any underwriters, dealers or agents who purchase Securities, as required;

              

         

        

      

      
        	 	
                •

              	
                the proposed selling price to the public;

              

         

        

      

      
        	 	
                •

              	
                any discount, commission or other underwriting compensation;

              

         

        

      

      
        4

        
          

      

      
        	 	
                •

              	
                the place and time of delivery for the Securities being sold;

              

         

        

      

      
        	 	
                •

              	
                any discount, commission or concession allowed, reallowed or paid to any dealers; and

              

         

        

      

      
        	 	
                •

              	
                any other material terms of the distribution of Securities.

              

      

       

      

      In addition, if the Selling Securityholder notifies us that a donee, pledgee, transferee or other successor-in-interest of the
        Selling Securityholder intends to sell any securities, we will file an amendment to the registration statement of which this prospectus forms a part of or a supplement to this prospectus, if required.

       

      
        5

        
          

      

      VENUS CONCEPT INC.

       

      SELLING SECURITYHOLDER NOTICE AND QUESTIONNAIRE

       

      The undersigned beneficial owner of common stock, $0.0001 par value per share (the “Common

          Stock”) of Venus Concept Inc. (the “Company”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a Registration Statement for the registration and resale of the Registrable Securities, in accordance with the terms of the Amended and Restated Resale Registration
        Rights Agreement, dated as of November 18, 2022 (the “Registration Rights Agreement”), among the Company and the 2022 Purchasers (as defined therein).  A copy of the Amended
        and Restated Resale Registration Rights Agreement is available from the Company upon request at the address set forth below.  All capitalized terms used and not otherwise defined herein will have the meanings ascribed thereto in the Amended and
        Restated Resale Registration Rights Agreement.

       

      The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

       

      	
              1.

            	
              Name.

            
	 	 
	 	
              (a)

            	
              Full Legal Name of Selling Securityholder

            
	 	 	 
	 	 	 
	 	
              (b)

            	
              Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:

            
	 	 	 
	 	 	 
	 	
              (c)

            	
              Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered
                by the questionnaire):

            
	 	 	 

      

      

      	
              2.

            	
              Address for Notices to Selling Securityholder:

            
	 	 
	 	
              Name:

            	 
	 	 	 
	 	
              Address:

            	 
	 	 	 
	 	 	 
	 	 	 
	 	
              Telephone:

            	 
	 	 	 
	 	
              Fax:

            	 
	 	 	 
	 	
              Contact Person:

            	 

      

      

      
        6

        
          

      

      	
              3.

            	
              Beneficial Ownership of Registrable Securities:

            
	 	 
	 	
              (a)

            	
              Type and Amount of Registrable Securities Beneficially Owned:

            
	 	 	 
	 	 	 

      

      

      	
              4.

            	
              Broker-Dealer Status:

            
	 	 	 
	 	
              (a)

            	
              Are you a broker-dealer?

            
	 	 	 
	 	
              

              

            	
              Yes ☐  No ☐

            
	 	 	 
	 	
              Note: If yes, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

            
	 	 
	 	
              (b)

            	
              Are you an affiliate of a broker-dealer?

            
	 	 	 
	 	
              

              

            	
              Yes ☐  No ☐

            
	 	 	 
	 	
              (c)

            	
              If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the
                Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

            
	 	 	 
	 	
              

              

            	
              Yes ☐  No ☐

            
	 	 	 
	 	
              Note: If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

            

      

      

      	
              5.

            	
              Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder.

            
	 	 
	 	
              Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities
                listed above in Item 3.

            
	 	 
	 	
              Type and Amount of Other Securities Beneficially Owned by the Selling Securityholder:

            
	 	 
	 	 
	 	 
	 	 
	 	 

      

      

      
        7

        
          

      

      
        
          	6.	Relationships with the Company:

        

      

       

      Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more
        of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

       

      	 	
              State any exceptions here:

            	 
	 	 
	 	 
	 	 
	 	 

       

      

      The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to
        the date hereof and prior to the Effective Date for the Registration Statement.

       

      By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 6 and the
        inclusion of such information in the Registration Statement and the related prospectus.  The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration
        Statement and the related prospectus.

       

      
        8

        
          

      

      IN WITNESS WHEREOF the
          undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

       

      	
              Dated:

            	
              Beneficial Owner:

            	 
	 	 	 
	
               

            	
               

            	 
	
               

            	
              By:

            	 	 
	 	 	 	 
	
               

            	
              Name:

            	 	 
	 	 	 	 
	
               

            	
              Title:

            	 	 

       

      PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

       

      Venus Concept Inc.

      ATTN: Michael Mandarello, General Counsel and Corporate Secretary

      235 Yorkland Blvd., Suite 900

      Toronto, ON M2J 4Y8

       

      

       

      

      9EX-4.1

 Exhibit 4.1 

EXECUTION VERSION 
  

 
 ONEOK, INC. 

as Issuer; ONEOK PARTNERS, L.P. 

and 
 ONEOK PARTNERS
INTERMEDIATE LIMITED PARTNERSHIP 
 as Guarantors; and 

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION 

as Trustee 
 NINETEENTH
SUPPLEMENTAL INDENTURE 
 Dated as of November 18, 2022 

to 
 INDENTURE 

relating to Securities Dated as of January 26, 2012 

6.100% Notes due 2032 
  

 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 ARTICLE 1 Relation to Indenture; Definitions and Other Provisions of General Application
	  	 	1	 
	 SECTION 1.01. Relation to Indenture
	  	 	1	 
	 SECTION 1.02. Definitions
	  	 	2	 
	 SECTION 1.03. General References
	  	 	3	 
		
	 ARTICLE 2 The Series of Securities
	  	 	3	 
	 SECTION 2.01. The Form and Title of the Securities
	  	 	3	 
	 SECTION 2.02. Amount
	  	 	3	 
	 SECTION 2.03. Stated Maturity
	  	 	4	 
	 SECTION 2.04. Interest and Interest Rates
	  	 	4	 
	 SECTION 2.05. Optional Redemption
	  	 	4	 
	 SECTION 2.06. Global Securities
	  	 	4	 
		
	 ARTICLE 3 Agreement to Guarantee
	  	 	4	 
	 SECTION 3.01. Unconditional Guarantee
	  	 	4	 
	 SECTION 3.02. Limitation on Guarantor Liability
	  	 	7	 
	 SECTION 3.03. No Requirement to Endorse Notation of Guarantee
	  	 	7	 
	 SECTION 3.04. Release of Guarantee
	  	 	7	 
	 SECTION 3.05. Benefits Acknowledged
	  	 	7	 
		
	 ARTICLE 4 Miscellaneous
	  	 	8	 
	 SECTION 4.01. Notices
	  	 	8	 
	 SECTION 4.02. No Recourse Against Others
	  	 	8	 
	 SECTION 4.03. Certain Trustee Matters
	  	 	8	 
	 SECTION 4.04. Continued Effect
	  	 	8	 
	 SECTION 4.05. Governing Law
	  	 	9	 
	 SECTION 4.06. Counterparts
	  	 	9	 

 EXHIBITS 
 Exhibit A:
Form of Note 

 NINETEENTH SUPPLEMENTAL INDENTURE, dated as of November 18, 2022 (this
“Supplemental Indenture”), among ONEOK, INC., an Oklahoma corporation (the “Company”), ONEOK PARTNERS, L.P., a Delaware
limited partnership, and ONEOK PARTNERS INTERMEDIATE LIMITED PARTNERSHIP, a Delaware limited partnership (each a
“Guarantor” and together, the “Guarantors”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
(successor in interest to U.S. Bank National Association), as trustee under the Indenture referred to below (in such capacity, the “Trustee”). 

RECITALS OF THE COMPANY 

WHEREAS, the Company and the Trustee have heretofore entered into an Indenture, dated as of January 26, 2012 (the “Original
Indenture”) (the Original Indenture, as amended and supplemented from time to time, including without limitation pursuant to this Supplemental Indenture, being referred to herein as the “Indenture”); and 

WHEREAS, under the Original Indenture, a new series of Securities may at any time be established by the Board of Directors of the Company, in
accordance with the provisions of the Original Indenture, and the terms of such series may be established by an indenture supplemental to the Original Indenture; and 

WHEREAS, the Company proposes to create under the Indenture a new series of Securities; and 

WHEREAS, in connection with the issuance of the Notes (as herein defined), each of the Guarantors desires to become a guarantor of, and
provide a guarantee of, the Notes; and 
 WHEREAS, all acts and things necessary to make the Notes and Guarantees (as herein defined), when
executed by the Company and the Guarantors, respectively, and when the Notes are authenticated and delivered by the Trustee as provided in the Original Indenture and this Supplemental Indenture, the valid and binding obligations of the Company and
the Guarantors, and to make this Supplemental Indenture a valid and binding agreement in accordance with the Original Indenture have been done or performed. 

NOW, THEREFORE, in consideration of the premises, agreements and obligations set forth herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree, for the equal and proportionate benefit of all Holders of the Notes, as follows: 

ARTICLE 1 
 Relation to
Indenture; Definitions and 
 Other Provisions of General Application 

SECTION 1.01. Relation to Indenture. 

With respect to the Notes, this Supplemental Indenture constitutes an integral part of the Indenture. 

  
 1 

 SECTION 1.02. Definitions. 

Except as may be provided in a future indenture supplemental to the Original Indenture, for the benefit of the Holders of the Notes but no
other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Article One of the Original Indenture shall be amended by adding the following defined terms to Section 101 in appropriate alphabetical sequence.
For all purposes of this Supplemental Indenture, capitalized terms used herein and not otherwise defined herein shall have the meanings assigned thereto in the Original Indenture. 

“Par Call Date” means August 15, 2032 (three months prior to the maturity date of the Notes). 

“Treasury Rate” means, with respect to any Redemption Date, the yield determined by the Company in accordance with the
following two paragraphs. 
 The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as
yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected Interest Rates (Daily)—H.15” (or any successor
S-12 designation or publication) (“H.15”) under the caption “U.S. government securities—Treasury constant maturities—Nominal” (or any successor caption or heading).
In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the “Remaining
Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields—one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield
corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life—and shall interpolate to the Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result
to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of
this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date. 

If on the third business day preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the
Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such Redemption Date of the United States Treasury
security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities with a maturity
date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding
the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more United States Treasury securities meeting 

  
 2 

 
the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par
based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of
the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to
three decimal places. 
 SECTION 1.03. General References. 

All references in this Supplemental Indenture to Articles and Sections, unless otherwise specified, refer to the corresponding Articles and
Sections of this Supplemental Indenture; and the terms “herein,” “hereof,” “hereunder” and any other word of similar import refers to this Supplemental Indenture. 

ARTICLE 2 
 The Series of
Securities 
 SECTION 2.01. The Form and Title of the Securities. 

There is hereby established a new series of Securities to be issued under the Indenture and to be designated as the Company’s 6.100%
Notes due 2032 (the “Notes”). The Notes shall be substantially in the form attached as Exhibit A hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or
permitted by the Indenture, and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as the Company may deem appropriate or as may be required or appropriate to comply with any laws or with
any rules made pursuant thereto or with the rules of any securities exchange or automated quotation system on which the Notes may be listed or traded, or to conform to general usage, or as may, consistently with the Indenture, be determined by the
officers executing such Notes, as evidenced by their execution thereof. The Notes and any beneficial interest in the Notes shall be in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. 

The Notes shall be executed, authenticated and delivered in accordance with the provisions of, and shall in all respects be subject to, the
terms, conditions and covenants of the Original Indenture as supplemented by this Supplemental Indenture (including the form of Note set forth as Exhibit A hereto (the terms of which are incorporated in and made a part of this Supplemental
Indenture for all intents and purposes)). 
 SECTION 2.02. Amount. 

The aggregate principal amount of the Notes which may be authenticated and delivered pursuant hereto is unlimited. The Trustee shall initially
authenticate and deliver Notes for original issue in an initial aggregate principal amount of up to $750,000,000 upon delivery to the Trustee of a Company Order for the authentication and delivery of such Notes. The aggregate principal amount of the
Notes to be issued hereunder may be increased at any time hereafter and the series may be reopened for issuances of additional Notes upon Company Order without the consent of any Holder. The Notes issued on the date hereof and any such additional
Notes that may be issued hereafter shall be part of the same series of Securities for all purposes under the Indenture. 

  
 3 

 SECTION 2.03. Stated Maturity. 

The Notes may be issued on any Business Day on or after November 18, 2022, and the Stated Maturity of the Notes shall be
November 15, 2032. 
 SECTION 2.04. Interest and Interest Rates. 

The rate or rates at which the Notes shall bear interest, the date or dates from which such interest shall accrue, the interest payment dates
on which any such interest shall be payable and the regular record date for any interest payable on any interest payment date, in each case, shall be as set forth in the form of Note set forth as Exhibit A hereto. 

SECTION 2.05. Optional Redemption. 

At its option, the Company may redeem the Notes, in whole or in part, in principal amounts of $2,000 and in integral multiples of $1,000 in
excess thereof, at any time or from time to time, at the applicable redemption price determined as set forth in the form of Note attached hereto as Exhibit A, in accordance with the terms set forth in the Notes and in accordance with Article
Eleven of the Original Indenture. 
 SECTION 2.06. Global Securities. 

The Notes shall initially be issuable in whole or in part in the form of one or more Global Securities. Such Global Securities (i) shall
be deposited with, or on behalf of, The Depository Trust Company, which shall act as Depositary with respect to the Notes, (ii) shall bear the legends applicable to Global Securities set forth in Section 204 of the Original Indenture,
(iii) may be exchanged in whole or in part for Notes in definitive form upon the terms and subject to the conditions provided in Section 304 of the Original Indenture and in this Supplemental Indenture and (iv) shall otherwise be
subject to the applicable provisions of the Indenture. 
 ARTICLE 3 

Agreement to Guarantee 

SECTION 3.01. Unconditional Guarantee. 

(a) For value received, subject to Section 3.04 hereof, each of the Guarantors hereby fully, irrevocably, unconditionally and absolutely
guarantees to the Holders of the Notes and to the Trustee the due and punctual payment of the principal of, and premium, if any, and interest on such Notes, and all other amounts due and payable under the Indenture and such Notes by the Company to
the Trustee or such Holders (including, without limitation, all costs and expenses (including reasonable legal fees and disbursements of its agents and counsel) incurred by the Trustee or such Holders in connection with the enforcement of the
Indenture and the Guarantees) (collectively, the “Indenture Obligations”), when and as such amounts shall become due and payable, whether at the Stated Maturity, upon redemption or by declaration of acceleration or otherwise,
according to the terms of such Notes and the Indenture. The guarantees by the 

  
 4 

 
Guarantors set forth in this ARTICLE 3 are referred to herein as the “Guarantees.” Without limiting the generality of the foregoing, each Guarantor’s liability shall
extend to all amounts that constitute part of the Indenture Obligations and would be owed by the Company to the Trustee or such Holders under the Indenture and such Notes but for the fact that they are unenforceable, reduced, limited, impaired,
suspended or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving the Company. 
 (b) Failing
payment when due of any amount guaranteed pursuant to the Guarantees, for whatever reason, each Guarantor will be obligated (to the fullest extent permitted by applicable law) to pay the same immediately to the Trustee, without set-off or counterclaim or other reduction whatsoever (whether for taxes, withholding or otherwise). The Guarantees hereunder are intended to be a general, unsecured, senior obligation of each Guarantor and will
rank pari passu in right of payment with all unsecured indebtedness of such Guarantor that is not, by its terms, expressly subordinated in right of payment to the Guarantees of such Guarantor. Each Guarantor hereby agrees that, to the fullest
extent permitted by applicable law, subject to Section 3.04 hereof, its obligations hereunder shall be full, irrevocable, unconditional and absolute, irrespective of the validity, regularity or enforceability of such Notes, the Guarantees or
the Indenture, the absence of any action to enforce the same, any waiver or consent by any such Holder with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other
circumstance which might otherwise constitute a legal or equitable discharge or defense of such Guarantor. Each Guarantor hereby agrees that in the event of a default in payment of any Indenture Obligations, whether at the Stated Maturity, upon
redemption or by declaration of acceleration or otherwise, legal proceedings may be instituted by the Trustee on behalf of such Holders or, subject to Section 507 of the Indenture, by such Holders, on the terms and conditions set forth in the
Indenture, directly against such Guarantor to enforce the Guarantees without first proceeding against the Company. 
 (c) To the fullest
extent permitted by applicable law, subject to Section 3.04 hereof, the obligations of each Guarantor under this ARTICLE 3 shall be as aforesaid full, irrevocable, unconditional and absolute and shall not be impaired, modified, discharged,
released or limited by any occurrence or condition whatsoever, including, without limitation, (i) any compromise, settlement, release, waiver, renewal, extension, indulgence or modification of, or any change in, any of the obligations and
liabilities of the Company or either Guarantor contained in any of such Notes or the Indenture, (ii) any impairment, modification, release or limitation of the liability of the Company, either Guarantor or any of their estates in bankruptcy, or
any remedy for the enforcement thereof, resulting from the operation of any present or future provision of any applicable Bankruptcy Law, as amended, or other statute or from the decision of any court, (iii) the assertion or exercise by the
Trustee or any such Holder of any rights or remedies under any of such Notes or the Indenture or their delay in or failure to assert or exercise any such rights or remedies, (iv) the assignment or the purported assignment of any property as
security for any of such Notes, including all or any part of the rights of the Company or either Guarantor under the Indenture, (v) the extension of the time for payment by the Company or either Guarantor of any payments or other sums or any
part thereof owing or payable under any of the terms and provisions of any of such Notes or the Indenture or of the time for performance by the Company or either Guarantor of any other obligations under or arising out of any such terms and
provisions or the extension or the renewal of any thereof, (vi) the modification or amendment (whether material or otherwise) of any duty, agreement or obligation of the Company or either Guarantor set forth in

  
 5 

 
the Indenture, (vii) the voluntary or involuntary liquidation, dissolution, sale or other disposition of all or substantially all of the assets, marshaling of assets and liabilities,
receivership, insolvency, bankruptcy, assignment for the benefit of creditors, reorganization, arrangement, composition or readjustment, rehabilitation or relief of, or other similar proceeding affecting, the Company or either Guarantor or any of
their respective assets, or the disaffirmance of any of such Notes, the Guarantees or the Indenture in any such proceeding, (viii) the release or discharge of the Company or either Guarantor from the performance or observance of any agreement,
covenant, term or condition contained in any of such instruments by operation of law, (ix) the unenforceability of any of such Notes, the Guarantees or the Indenture, (x) any change in the name, business, capital structure, corporate
existence, or ownership of the Company or either Guarantor, or (xi) any other circumstance which might otherwise constitute a defense available to, or a legal or equitable discharge of, a surety or either Guarantor. 

(d) To the fullest extent permitted by applicable law, each Guarantor hereby (i) waives diligence, presentment, demand of payment,
notice of acceptance, filing of claims with a court in the event of the merger, insolvency or bankruptcy of the Company or such Guarantor, and all demands and notices whatsoever, (ii) acknowledges that any agreement, instrument or document
evidencing the Guarantees may be transferred and that the benefit of its obligations hereunder shall extend to each holder of any agreement, instrument or document evidencing the Guarantees without notice to them and (iii) covenants that its
Guarantees will not be discharged except by complete performance of the Guarantees. To the fullest extent permitted by applicable law, each Guarantor further agrees that if at any time all or any part of any payment theretofore applied by any Person
to any Guarantees is, or must be, rescinded or returned for any reason whatsoever, including without limitation, the insolvency, bankruptcy or reorganization of either Guarantor, such Guarantees shall, to the extent that such payment is or must be
rescinded or returned, be deemed to have continued in existence notwithstanding such application, and the Guarantees shall continue to be effective or be reinstated, as the case may be, as though such application had not been made. 

(e) Each Guarantor shall be subrogated to all rights of the Holders and the Trustee against the Company in respect of any amounts paid by
such Guarantor pursuant to the provisions of the Indenture; provided, however, that such Guarantor shall not be entitled to enforce or to receive any payments arising out of, or based upon, such right of subrogation with respect to any
of such Notes until all of such Notes and the Guarantees shall have been indefeasibly paid in full or discharged. 
 (f) To the fullest
extent permitted by applicable law, no failure to exercise and no delay in exercising, on the part of the Trustee or the Holders, any right, power, privilege or remedy under this ARTICLE 3 and the Guarantees shall operate as a waiver thereof, nor
shall any single or partial exercise of any rights, power, privilege or remedy preclude any other or further exercise thereof, or the exercise of any other rights, powers, privileges or remedies. The rights and remedies herein provided for are
cumulative and not exclusive of any rights or remedies provided in law or equity. Nothing contained in this ARTICLE 3 shall limit the right of the Trustee or the Holders to take any action to accelerate the maturity of such Notes pursuant to Article
FIVE of the Indenture or to pursue any rights or remedies under the Indenture or under applicable law. 

  
 6 

 SECTION 3.02. Limitation on Guarantor Liability. 

Each Guarantor and the Trustee hereby confirms that it is the intention of all such parties that the Guarantees of such Guarantor not
constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Guarantees. To effectuate
the foregoing intention, the Trustee and the Guarantors hereby irrevocably agree that the obligations of such Guarantor will be limited to the maximum amount that will, after giving effect to such maximum amount and all other contingent and fixed
liabilities of such Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of the other Guarantor in respect of the obligations of such other
Guarantor under this ARTICLE 3, result in the obligations of such Guarantor under its Guarantees not constituting a fraudulent transfer or conveyance. 

SECTION 3.03. No Requirement to Endorse Notation of Guarantee. 

Each Guarantor hereby agrees that its execution and delivery of this Supplemental Indenture and the provisions set forth in this ARTICLE 3
shall evidence its Guarantee without the need for notation on any Notes. 
 SECTION 3.04. Release of Guarantee.

 (a) Notwithstanding anything to the contrary in this ARTICLE 3, if a Guarantor (i) shall cease to be a subsidiary of the Company or
(ii) shall no longer be (x) an obligor on, or issuer of, any capital markets debt securities or (y) a guarantor of any capital markets debt securities issued by the Company or the other Guarantor, in each case other than the Notes,
then, if no Default or Event of Default shall have occurred and be continuing, such Guarantor, upon giving written notice to the Trustee to the foregoing effect, shall be deemed to be released from all of its obligations under the Indenture, and the
Guarantees shall be of no further force or effect with respect to such Guarantor. Following the receipt by the Trustee of any such notice, the Company shall cause the Indenture to be amended as provided in Section 901 of the Indenture;
provided, however, that the failure to so amend the Indenture shall not affect the validity of the termination of the Guarantees with respect to such Guarantor. 

(b) In addition, upon (i) the exercise of the legal defeasance or covenant defeasance option or the satisfaction and discharge of the
Indenture as provided in ARTICLES FIFTEEN and FOUR, respectively, of the Indenture with respect to a series of Notes or (ii) a series of Notes ceasing to be Outstanding, each of the Guarantors shall be deemed to be released from all its
obligations under the Indenture with respect to such series of Notes and the Guarantees of such series of Notes shall be of no further force or effect. 

SECTION 3.05. Benefits Acknowledged. 

Each Guarantor acknowledges that it shall receive direct and indirect benefits from the financing arrangements contemplated by the Indenture
and from the Guarantees under this Supplemental Indenture. 

  
 7 

 ARTICLE 4 

Miscellaneous 

SECTION 4.01. Notices. 

Notices to the Guarantor shall be made in accordance with Section 105 of the Indenture at the address for the Company set forth in such
Section. 
 Notices to the Trustee shall be made in accordance with Section 105 of the Indenture at the Corporate Trust Office,
currently located at 2 Concourse Parkway, Suite 800, Atlanta, Georgia 30328 Attention: Corporate Trust Department. 

SECTION 4.02. No Recourse Against Others. 

No director, officer, employee, partner (including, for greater certainty, any general partner of any general partnership who is an individual
person), incorporator, manager, stockholder or member of either Guarantor, as such, will have any liability for any obligations of the Company, such Guarantor or the other Guarantor under the Notes or the Indenture or for any claim based on, in
respect of, or by reason of, such obligations or their creation. The waiver and release are part of the consideration for the issuance of the Guarantees and the Notes. 

SECTION 4.03. Certain Trustee Matters. 

The recitals contained herein and in the Notes, except for the Trustee’s Certificate of Authentication, shall be taken as the statements
of the Company and the Guarantors, and the Trustee assumes no responsibility for their correctness. 
 The Trustee makes no representations
as to the validity or sufficiency of this Supplemental Indenture or the Notes or the proper authorization or the due execution hereof or thereof by the Company or any of the Guarantors. 

Except as expressly set forth herein, nothing in this Supplemental Indenture shall alter the duties, rights, privileges, immunities or
obligations of the Trustee set forth in the Original Indenture, which shall be applicable in respect of the Notes and of this Supplemental Indenture as fully and with like effect as if set forth herein in full. 

The Trustee makes no representation or warranty as to the validity or sufficiency of the information contained in the prospectus supplement or
other disclosure materials related to the Notes, except such information which specifically pertains to the Trustee itself, or any information incorporated therein by reference with respect to the Trustee. 

SECTION 4.04. Continued Effect. 

Except as expressly supplemented and amended by this Supplemental Indenture, the Original Indenture shall continue in full force and effect in
accordance with the provisions thereof, and the Original Indenture (as supplemented and amended by this Supplemental Indenture) is in all respects hereby ratified and confirmed. This Supplemental Indenture and all its provisions shall be deemed a
part of the Original Indenture in the manner and to the extent herein and therein provided. 

  
 8 

 SECTION 4.05. Governing Law. 

This Supplemental Indenture and the Notes shall be governed by and construed in accordance with the laws of the State of New York. This
Supplemental Indenture and the Notes are subject to the provisions of the Trust Indenture Act that are required to be part of this Supplemental Indenture and the Notes and shall, to the extent applicable, be governed by such provisions. 

SECTION 4.06. Counterparts. 

This instrument may be executed in any number of counterparts, each of which, when delivered, shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument. 
 (Signature Pages Follow) 

  
 9 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and delivered, all as of the day and year first above written. 
  

			
	ONEOK, INC.
		
	By:	 	/s/ Pierce H. Norton II
	Name:	 	Pierce H. Norton II
	Title:	 	President and Chief Executive Officer
	
	ONEOK PARTNERS, L.P.
		
	By:	 	 ONEOK Partners GP, L.L.C.,
 its General
Partner

		
	By:	 	/s/ Walter S. Hulse III
	Name:	 	Walter S. Hulse III
	Title:	 	Chief Financial Officer, Treasurer and Executive Vice President, Investor Relations and Corporate Development
	
	ONEOK PARTNERS INTERMEDIATE LIMITED PARTNERSHIP
		
	By:	 	 ONEOK ILP GP, L.L.C.,
 its General
Partner

		
	By:	 	/s/ Walter S. Hulse III
	Name:	 	Walter S. Hulse III
	Title:	 	Chief Financial Officer, Treasurer and Executive Vice President, Investor Relations and Corporate Development

  
 [Signature Page to
Nineteenth Supplemental Indenture] 

 
			
	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
	as Trustee
		
	By:	 	/s/ David W. Ferrell
	Name:	 	David W. Ferrell
	Title:	 	Vice President

  
 [Signature Page to
Nineteenth Supplemental Indenture] 

 EXHIBIT A 

[FORM OF FACE OF NOTE] 
 [If a Global
Security, insert—UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO.,
OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &
CO., HAS AN INTEREST HEREIN.] 
 [If a Global Security, insert—TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT
IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE, AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO
HEREIN.] 
 ONEOK, INC. 

6.100% Note due 2032 
  

					
	No.                	  		  	U.S. $                

 CUSIP No. 682680 BG7 

ONEOK, Inc., an Oklahoma corporation (herein called the “Company”, which term includes any successor Person under the Indenture
hereinafter referred to), for value received, hereby promises to pay to, _________________________ or registered assigns, the principal sum of _______________ United States Dollars ($_______________) on November 15, 2032, the stated maturity
date, and to pay interest thereon from November 18, 2022, or from the most recent interest payment date to which interest has been paid or duly provided for, semi-annually on May 15 and November 15 in each year, commencing on
May 15, 2023, at the rate of 6.100% per annum, until the principal hereof is paid or made available for payment and at the same rate per annum on any overdue principal and premium and on any overdue installment of interest. The amount of
interest payable for any period shall be computed on the basis of twelve 30-day months and a 360-day year. The amount of interest payable for any partial period shall be
computed on the basis of a 360-day year of twelve 30-day months and the days elapsed in any partial month. In the event that any date on which interest is payable on
this Note is not a Business Day, then a payment of the interest payable on such date will be made on the next succeeding day which is a Business Day (and without any interest or other payment in respect of any such delay) with the same force and
effect as if made on the date the payment was originally payable. The interest so payable, and 

 
punctually paid or duly provided for, on any interest payment date will, as provided in such Indenture, be paid to the Person in whose name this Note (or one or more predecessor Notes) is
registered at the close of business on the regular record date for such interest, which record date shall be May 1 or November 1 (whether or not a Business Day), as the case may be, next preceding such interest payment date. Any such
interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holder on such regular record date and may either be paid to the Person in whose name this Note (or one or more predecessor Notes) is registered at the
close of business on a special record date for the payment of such Defaulted Interest to be fixed by the Trustee, notice of which shall be given to Holders of Notes not less than 10 days prior to such special record date, or be paid at any time in
any other lawful manner not inconsistent with the requirements of any securities exchange or automated quotation system on which the Notes may be listed or traded, and upon such notice as may be required by such exchange or automated quotation
system, all as more fully provided in the Indenture. 
 [If a Global Security, insert—Payment of the principal of (and premium, if any)
and any such interest on this Note will be made by transfer of immediately available funds to a bank account in the United States of America designated by the Holder to the Paying Agent in U.S. Dollars.] 

[If a definitive Security, insert—Payment of the principal of (and premium, if any) and any such interest on this Note will be made at
the office or agency of the Company maintained for that purpose in U.S. Dollars or subject to any laws or regulations applicable thereto and to the right of the Company (as provided in the Indenture) to rescind the designation of any such Paying
Agent, at the offices of ____________________, and at such other offices or agencies as the Company may designate, by U.S. Dollar check drawn on, or transfer to a U.S. Dollar account maintained by the payee with, a bank in The City of New
York (so long as the applicable Paying Agent has received proper transfer instructions in writing at least 10 days prior to the payment date); provided, however, that payment of interest may be made at the option of the Company by
U.S. Dollar check mailed to the addresses of the Persons entitled thereto as such addresses shall appear in the Security Register or by transfer to a U.S. Dollar account maintained by the payee with a bank in The City of New York (so long
as the applicable Paying Agent has received proper transfer instructions in writing by the record date prior to the applicable interest payment date).] 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated: _______________, _________ 
  

			
	ONEOK, INC.
		
	By:	 	 
	Name:	 	
	Title:	 	

  

			
	ATTEST
		
	By:	 	 
	Name:	 	
	Title:	 	

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	Dated:                    ,         
	
	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	 
		 	Authorized Signatory

 [REVERSE OF NOTE] 

ONEOK, INC. 
 6.100% Note
due 2032 
 This security is one of a duly authorized issue of debt securities of the Company (the “Securities”), issued and
to be issued in one or more series under an Indenture, dated as of January 26, 2012, between the Company and U.S. Bank Trust Company, National Association (successor in interest to U.S. Bank National Association), as trustee (the
“Trustee,” which term includes any successor trustee under the Indenture), as amended and supplemented to date, including without limitation by the Nineteenth Supplemental Indenture thereto, dated November 18, 2022 among the Company,
ONEOK Partners, L.P. and ONEOK Partners Intermediate Limited Partnership (each a “Guarantor” and together, the “Guarantors”) and the Trustee, (such Indenture, as so amended and supplemented being referred to herein as the
“Indenture”), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, obligations, duties and immunities thereunder of the Company, the
Guarantors, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof. The Securities of this series are
referred to herein as the “Notes.” 
 On or after the Par Call Date, the Notes will be subject to redemption at any time at the
option of the Company, in whole or in part, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid interest thereon to the applicable Redemption Date (subject to the right of holders of
record on the relevant record date to receive interest due on an Interest Payment Date that is on or prior to the Redemption Date). 
 Prior
to the Par Call Date, the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the
greater of: 
 (1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the
Redemption Date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury
Rate plus 35 basis points less (b) interest accrued to the Redemption Date, and 
 (2) 100% of the principal amount of the Notes to be
redeemed, 
 plus, in either case, accrued and unpaid interest thereon to the Redemption Date. 

The Company’s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. The Trustee shall not be responsible for calculating the redemption price or any component thereof. 
 Notice of any
redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary’s procedures) at least 15 days but not more than 60 days before the Redemption Date to each Holder of Notes to be redeemed. 

 Unless the Company defaults in payment of the redemption price, on and after the Redemption
Date, interest will cease to accrue on this Note or the portions hereof called for redemption. 
 In the event of redemption of this Note in
part only, a new Note or Notes of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 

The Indenture contains provisions for defeasance at any time of (1) the entire indebtedness of this Note or (2) certain restrictive
covenants and Events of Default with respect to this Note, in each case upon compliance with certain conditions set forth in the Indenture. 

If an Event of Default with respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due and payable in
the manner and with the effect provided in the Indenture. 
 The Guarantors fully, irrevocably, unconditionally and absolutely guarantee the
due and punctual payment of the principal of, and premium, if any, and interest on such Notes, and all other amounts due and payable under the Indenture and such Notes by the Company to the Trustee or such Holders. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company, the Guarantors and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company, the Guarantors and the Trustee with the consent of not less than the Holders of a majority
in principal amount of the Outstanding Securities of each series to be affected. The Indenture also contains provisions permitting the Holders of a majority in principal amount of the Outstanding Securities of each affected series, on behalf of the
Holders of all Securities of such series, to waive compliance by the Company and the Guarantors with certain provisions of the Indenture. The Indenture permits, with certain exceptions as therein provided, the Holders of a majority in principal
amount of Securities of any series then Outstanding to waive past defaults under the Indenture with respect to such series and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder
and all holders of Notes of which this Note is a predecessor Note, whether or not notation of such consent or waiver is made upon this or any other Note. 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute any action or
proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to
the Notes, the Holders of not less than 25% in principal amount of the Notes at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default and offered the Trustee reasonable
indemnity against costs, expenses and liabilities to be incurred in compliance with such request and the Trustee shall not have received from the Holders of a majority in principal amount of Notes at the time Outstanding a direction inconsistent
with such request, and the Trustee shall have failed to institute any such proceeding for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the
enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

 No reference herein to the Indenture and no provision of this Note or of the Indenture shall
alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place(s) and rate, and in the currency, herein prescribed. 

[If a Global Security, insert—This Global Security or portion hereof may not be exchanged for definitive Securities of this series except
in the limited circumstances provided in the Indenture. 
 The holders of beneficial interests in this Global Security will not be entitled
to receive physical delivery of definitive Securities except as described in the Indenture and will not be considered the Holders thereof for any purpose under the Indenture.] 

[If a definitive Security, insert—As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this
Note is registerable in the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in The City of New York, or, subject to any laws or regulations applicable thereto and to the right of the
Company (limited as provided in the Indenture) to rescind the designation of any such transfer agent, at the offices of              in the Borough of Manhattan, The City of New
York, and at such other offices or agencies as the Company may designate, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his
attorney duly authorized in writing, and thereupon one or more new Notes of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.] 

The Notes are issuable only in registered form without coupons in denominations of $2,000 and any whole multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Notes are exchangeable for a like aggregate principal amount of Notes and of like tenor of a different authorized denomination, as requested by the Holder
surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange, but the Company may require
payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of
this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and
neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
 This Note shall be governed by and
construed in accordance with the laws of the State of New York. The Notes are subject to the provisions of the Trust Indenture Act that are required to be part of the Notes and shall, to the extent applicable, be governed by such provisions. 

 All terms used in this Note which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. 

 [If a definitive Security, insert as a separate page— 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto ______________________________ (Please Print or Typewrite
Name and Address of Assignee) the within instrument of ONEOK, INC. and does hereby irrevocably constitute and appoint ______________________ Attorney to transfer said instrument on the books of the within-named Company, with full power of
substitution in the premises. 
 Please Insert Social Security or 

Other Identifying Number of Assignee: 
  

							
	 	 		 	 
				
	Dated:	 	 	 		 	 
		 		 		 	 (Signature)

  

			
		
	Signature Guarantee:	 	 
		 	(Participant in a Recognized Signature Guaranty Medallion Program)

 NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within
instrument in every particular, without alteration or enlargement or any change whatever.] 

 [If a Global Security, insert as a separate page— 

SCHEDULE OF INCREASES OR DECREASES 

IN GLOBAL SECURITY 
 The
following increases or decreases in this Global Security have been made: 
  

									
	 Date of

Exchange
	  	 Amount of Decrease in
Principal Amount of this
Global
Security
	  	 Amount of Increase in
Principal Amount of this
Global
Security
	  	 Principal Amount of this
Global Security following
such
decrease (or increase)
	  	 Signature of authorized
officer of Trustee
or
Depositary]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]